GUMDROP : Understanding mechanisms of response and resistance to androgen-directed therapies in men with advanced prostate cancer through interrogation of tumor biopsies (with a focus on androgen receptor variants)

Description:This research is being done to see if an investigational radioactive drug called 18F-DCFBC can help us find cancer that has spread (metastatic disease) from its original site in people who have cancer in their prostate to other parts of their body.
Link:N/A (In JHU database repository)
Site:Johns Hopkins University
Principal Investigator:Emmanuel S. Antonarakis, MD